Showing 1 - 1 results of 1 for search '(((( _ mg decrease ) OR ( 25 mg decrease ))) OR ((( 5 we decrease ) OR ( _ we decrease ))))~', query time: 0.07s Refine Results
  1. 1

    1787 evaluation of transperineal prostatic administration of a PSA-activasted protoxin (PRX302) in men with luts secondary to BPH by Elhilali, Mostafa

    Published 2010
    “…The concentration of PRX302 increased from 0.75 to 10.5mg/ml at a volume of 0.25-1.3 ml/deposit. In the Phase II study, 18 patients were enrolled in 3 cohorts and treated transperineally with a 3 mg/mL fixed concentration of PRX302 and at volumes equivalent to 10%, 20% and 30% of prostate volume. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article